Literature DB >> 9638020

Acquired von Willebrand's disease.

B J Hennessy1, B White, M Byrne, O P Smith.   

Abstract

von Willebrand's disease (vWD) is the commonest inherited bleeding disorder in man with an estimated incidence of 1 per thousand of the population. Acquired von Willebrand's disease (AvWD) is rare with less than 70 cases reported. AvWD is usually associated with autoimmune or clonal proliferation disorders and whilst the precise mechanism of acquired deficiency of von Willebrand factor (vWF) is poorly understood, the most likely candidate mechanism(s) are; antibodies inactivate or form a complex with immunologic or functional sites on vWF, or vWF multimers are selectively absorbed by malignant cells. Unlike hereditary vWD, the acquired form of the disease can be exceedingly difficult to manage. We report 4 cases of AvWD diagnosed at our centre over the past 3 yr. There was no evidence of a previous personal or family history of bleeding in any of the patients and AvWD was confirmed by laboratory testing. All 4 patients had a recognised primary medical condition known to be associated with AvWD (Waldenstrom's Macroglobulinaemia in 2 patients, hypothyroidism in 1 patient and monoclonal gammopathy of unknown significance (MGUS) in 1 patient). The acquired haemostatic defect corrected following treatment of the primary condition in 3 patients with the other patient requiring on demand von Willebrand Factor replacement to control spontaneous and surgery induced bleeding.

Entities:  

Mesh:

Year:  1998        PMID: 9638020     DOI: 10.1007/bf02937942

Source DB:  PubMed          Journal:  Ir J Med Sci        ISSN: 0021-1265            Impact factor:   1.568


  50 in total

Review 1.  Acquired von Willebrand's disease.

Authors:  J L Jakway
Journal:  Hematol Oncol Clin North Am       Date:  1992-12       Impact factor: 3.722

2.  Effectiveness of high-dose intravenous immunoglobulin in a case of acquired von Willebrand syndrome with chronic melena not responsive to desmopressin and factor VIII concentrate.

Authors:  G Castaman; A Tosetto; F Rodeghiero
Journal:  Am J Hematol       Date:  1992-10       Impact factor: 10.047

3.  Abnormalities of von Willebrand factor in myeloproliferative disease: a relationship with bleeding diathesis.

Authors:  F Fabris; A Casonato; M Grazia del Ben; L De Marco; A Girolami
Journal:  Br J Haematol       Date:  1986-05       Impact factor: 6.998

4.  DDAVP infusion in five patients with type Ia glycogen storage disease and associated correction of prolonged bleeding times.

Authors:  G E Marti; M E Rick; J Sidbury; H R Gralnick
Journal:  Blood       Date:  1986-07       Impact factor: 22.113

5.  Acquired von Willebrand's disease. Evidence for a quantitative and qualitative factor VIII disorder.

Authors:  J H Joist; J F Cowan; T S Zimmerman
Journal:  N Engl J Med       Date:  1978-05-04       Impact factor: 91.245

6.  Platelet dysfunction associated with Wilms tumor and hyaluronic acid.

Authors:  A W Bracey; A H Wu; J Aceves; T Chow; S Carlile; W K Hoots
Journal:  Am J Hematol       Date:  1987-03       Impact factor: 10.047

7.  Acquired von Willebrand's disease caused by a monoclonal antibody.

Authors:  O Zettervall; I M Nilsson
Journal:  Acta Med Scand       Date:  1978

8.  Acquired von Willebrand Disease in Patients with Chronic Myeloproliferative Disorders.

Authors:  W Tatewaki; A Shibata
Journal:  Leuk Lymphoma       Date:  1989

9.  Acquired von Willebrand's syndrome due to an inhibitor of IgG specific for von Willebrand's factor in polycythemia rubra vera.

Authors:  H Mohri; T Ohkubo
Journal:  Acta Haematol       Date:  1987       Impact factor: 2.195

10.  Acquired type II von Willebrand's disease: demonstration of a complexed inhibitor of the von Willebrand factor-platelet interaction and response to treatment.

Authors:  J Goudemand; B Samor; C Caron; B Jude; D Gosset; C Mazurier
Journal:  Br J Haematol       Date:  1988-02       Impact factor: 6.998

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.